Q1w Dosing
Research payments
$3,650,830
Through program year 2024, $3,650,830 in research payments was reported against Q1w Dosing, across 223 payments, paid by Genentech, Inc..
- Paid by
- Genentech, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $96,674 | 6 |
| 2023 | Research | $301,727 | 34 |
| 2022 | Research | $1,172,819 | 88 |
| 2021 | Research | $2,047,512 | 91 |
| 2020 | Research | $32,099 | 4 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
6 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.